01
Telomere Biology
Investigated in cell-culture models of telomere maintenance and replicative ageing.
For research use only — not for human consumption

Longevity & Cellular Research
In stockFOXO4-DRI is a synthetic peptide designed to disrupt FOXO4-p53 interactions and is studied in cellular senescence and aging pathway research models.
Professional pricing
Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.
Sign in for pricingSpecifications
Lot & handling
Molecular
Analytics
When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.
01
Chromatographic purity against a qualified reference standard.
02
Identity by observed versus theoretical molecular mass.
03
Residual moisture in lyophilized material.
04
Contaminant screening on raw material and finished lots.

Research background
Summary of the published literature this reference material is used in.
01
Investigated in cell-culture models of telomere maintenance and replicative ageing.
02
Studied for reported effects on transcriptional regulation in experimental systems.
03
Referenced in literature examining cellular senescence markers in vitro.
FOXO4-DRI was developed to selectively interfere with the binding between FOXO4 and p53, a pathway associated with senescent cell survival [1]. Research models investigate how this disruption influences senescence-associated signaling and transcriptional regulation.
Studies involving FOXO4-DRI examine senescent cell markers, apoptosis-related signaling, and stress-response pathways [2]. These investigations contribute to broader research into aging-associated cellular mechanisms.
The D-retro-inverso (DRI) design improves peptide stability and resistance to degradation, making it suitable for controlled pathway analysis [1].
Key Specs
Referenced Citations
Mandatory research disclaimer
All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.
Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.
These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.